The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:161–169. The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleg...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ff6f8e06fd324e2fafbb279707c4d5b3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ff6f8e06fd324e2fafbb279707c4d5b3 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ff6f8e06fd324e2fafbb279707c4d5b32021-12-02T09:14:56ZThe Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]1179-1438https://doaj.org/article/ff6f8e06fd324e2fafbb279707c4d5b32020-04-01T00:00:00Zhttps://www.dovepress.com/eoc-the-parkinson39s-disease-death-rate-carbidopa-and-vitami-peer-reviewed-article-CPAAhttps://doaj.org/toc/1179-1438Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:161–169. The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors for the published article. Clinical Pharmacology: Advances and Applications would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original articleHinz MStein ACole TDove Medical Pressarticlel-dopalevodopavitamin-b6plppyridoxal 5-phosphateTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol Volume 12, Pp 43-44 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
l-dopa levodopa vitamin-b6 plp pyridoxal 5-phosphate Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
l-dopa levodopa vitamin-b6 plp pyridoxal 5-phosphate Therapeutics. Pharmacology RM1-950 Hinz M Stein A Cole T The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| description |
Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:161–169.
The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article.
Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors for the published article. Clinical Pharmacology: Advances and Applications would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation.
The authors have been informed of these concerns and of our investigation.
Read the original article |
| format |
article |
| author |
Hinz M Stein A Cole T |
| author_facet |
Hinz M Stein A Cole T |
| author_sort |
Hinz M |
| title |
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| title_short |
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| title_full |
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| title_fullStr |
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| title_full_unstemmed |
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] |
| title_sort |
parkinson’s disease death rate: carbidopa and vitamin b6 [expression of concern] |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/ff6f8e06fd324e2fafbb279707c4d5b3 |
| work_keys_str_mv |
AT hinzm theparkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern AT steina theparkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern AT colet theparkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern AT hinzm parkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern AT steina parkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern AT colet parkinsonrsquosdiseasedeathratecarbidopaandvitaminb6expressionofconcern |
| _version_ |
1718398222110556160 |